Here's the first phase flight plan for return of Indian nationals stranded abroad

Hubli, Jun 12: An inspector of Hubli Rural police station on Friday was suspended for delaying the submission of a charge sheet in the matter relating to sedition charges against three Kashmiri students for making a video with pro-Pakistan slogan.

A second Joint Magistrate First Class (JMFC) court in February sent the three students, identified as Basit Ashik Sophi (19), Talib Majid (19) and Amir Mohiuddin (23), to police custody till February 28.

The Kashmiri students are under judicial custody since February 17 following their arrest for raising pro-Pakistan slogans and posting a video of the same on social media on the night of February 16.

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Mangaluru, Apr 16: An old refrigerator has been turned into a "disinfection chamber" by researchers who are striving to come up with solutions to tackle the spread of coronavirus.

Dr Arun M Isloor, head of Chemistry Department, National Institute of Technology Karnataka (NITK), Surathkal, along with research scholar Syed Ibrahim has come up with the device which can disinfect items kept inside it.

"We have named this as ZERO-COV," Dr Isloor said.

He says the device ensures 99.9 per cent destruction of microorganisms present on the surface of items.

"We can keep items like vegetables, currency notes, books or envelopes inside the chamber. Switching on the chamber for 15 minutes ensures 99.9 per cent destruction of microorganisms present in the surface of the items," Dr Isloor added.